Brief: Ascelia Pharma Q3 EBIT SEK -15.3 Million

Ascelia Pharma AB

05/11/2025 06:30

Nov 05 (Reuters) - Ascelia Pharma Q3 cash flow from operations SEK -15.7 million.

Q3 EPS SEK -0.13